100 Million Covid-19 Vaccine Doses to be Produced in Africa
Pfizer and BioNTech have reached an agreement with a South African company to produce their COVID-19 vaccine for distribution in Africa, Voice of America reports. The Biovac Institute in Cape Town will manufacture 100 million doses of the vaccine annually, starting in 2022. The company will mix vaccine ingredients it receives from Europe, place them in vials and package them for distribution to the 54 countries in Africa.
The agreement may eventually help alleviate vaccine shortages on a continent where the Africa Centers for Disease Control and Prevention says less than 2% of its population of 1.3 billion has received at least one dose. Pfizer CEO Albert Bourla said the company's goal is to provide people throughout Africa with the vaccine, a departure from previous bilateral agreements that saw most doses being sold to wealthy countries.
Calls for Africa to be an equal partner in the Covid-19 vaccine manufacturing process have been made previously, notably by President Paul Kagame of Rwanda who spoke at the Qatar Economic Forum in June 2021.
Pfizer, BioNTech Agree to Produce Covid-19 Vaccine in Africa
VOA, 21 July 2021
Pfizer and BioNTech have reached an agreement with a South African company to produce their COVID-19 vaccine for distribution in Africa, the biotechnology companies said Wednesday. Read more »
South African President Welcomes Biovac-Pfizer Deal
SAnews.gov.za, 21 July 2021
The African Union Champion on COVID-19, President Cyril Ramaphosa, has welcomed the announcement that the Pfizer COVID-19 vaccine will be produced in Cape Town by the Biovac… Read more »
Pfizer and BioNTech Announce Collaboration to Manufacture and Distribute Covid-19 Vaccine Doses Within Africa
Pfizer, 21 July 2021
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape… Read more »
Biovac Seals Deal to Manufacture Pfizer-BioNTech Vaccine
SAnews.gov.za, 21 July 2021
Cape Town-based specialist biotech company, Biovac, has reached a deal to manufacture the Pfizer-BioNTech COVID-19 vaccine for distribution within the African Union (AU). Read more »
President Cyril Ramaphosa Welcomes Biovac-Pfizer Collaboration
South Africa, 21 July 2021
President Cyril Ramaphosa has welcomed today’s announcement of a collaboration between South Africa’s Biovac Institute and the global pharmaceutical producer Pfizer as… Read more »
A plan by the European Union (EU) not to recognise Covid-19 vaccines manufactured outside the block could set back global efforts to contain the pandemic, writes Adhere Cavince for ... Read more »
Rwanda President Paul Kagame has said the African continent has to be an equal partner with the rest of the world when it comes to manufacturing vaccines instead of waiting for ... Read more »
Pfizer World Headquarters in New York City (file photo).